Lewicki John A.
- SEC CIK
- 0001553352
No open-market purchases or sales filed in the past year.
Current role at each company
- MREO Mereo BioPharma Group plcChief Scientific Officeras of Feb 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lewicki John A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2024 (view filing) | Sep 12-13 | 4 days | Lewicki John A.Chief Scientific Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −16.1K | $4.30 | −$69.5K | −17.0%78.6K after | 2 lots |
| Jun 27, 2024 (view filing) | Jun 25-26 | 2 days | Lewicki John A.Chief Scientific Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −24.2K | $3.48 | −$84.3K | −33.2%48.8K after | 2 lots |